貝因美(002570.SZ):宜昌工廠嬰兒配方奶粉品類已轉移至杭州工廠生產
格隆匯2月19日丨貝因美(002570.SZ)公佈,為響應國家疫情防控、經濟發展和人民羣眾生活保障號召,切實滿足特殊時期的市場需要。春節期間,公司統籌安排配合多地政府保供產品要求,切實根據訂單需求克服困難合理安排生產計劃,黑龍江貝因美乳業有限公司始終保持生產工作穩步運行。節後,公司在嚴格做好疫情防控措施的基礎上,進一步有力有序推進下屬各生產主體企業復工復產。截止目前,公司下屬生產型子公司除湖北宜昌工廠外均已實現全面復工(宜昌工廠的嬰兒配方奶粉品類經國家市場監督管理總局同意已轉移至杭州工廠生產)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.